Insulin Biosimilars Market - Advantages, Opportunities and Challenges Until 2026
Diabetes is caused by increase in blood sugar level due to inadequate secretion of insulin. Increased hunger, tiredness, weight loss, and excessive thirst and urination are some of the symptoms of the metabolic disease. High prevalence of diabetes is expected to propel growth of the insulin biosimilars market. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million people died due to the disease in 2012. Insulin...
View full press release